Breaking News
October 22, 2018 - Targeting specific genomic mutation in breast cancer improves survival
October 22, 2018 - Loss of tumor protein p53 helps cancer cells grow in hostile environment
October 22, 2018 - IDT to demonstrate CRISPR expertise at European-focused events
October 22, 2018 - Breathing through the nose improves memory consolidation
October 22, 2018 - Recreational Marijuana Now Legal in Canada
October 22, 2018 - Scientists reveal drumming helps schoolchildren diagnosed with autism
October 22, 2018 - A stage IV cancer patient discusses what it means to live well with serious illness
October 22, 2018 - In Kids with Autism, Short Questionnaire May Detect GI Disorders
October 22, 2018 - Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas
October 22, 2018 - Aspirin may be effective in preventing blood clots after knee replacement
October 22, 2018 - Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting
October 22, 2018 - Immunotherapy with pembrolizumab extends survival in metastatic or recurrent head and neck cancer
October 22, 2018 - Health Tip: Keep Ticks Away
October 22, 2018 - Obsessive-compulsive disorder – Genetics Home Reference
October 22, 2018 - Researchers find disrupted functional connectivity in cerebellum of adults with HF-ASD
October 22, 2018 - Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors
October 22, 2018 - Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma
October 22, 2018 - Overcoming bottlenecks in early drug discovery with the power of sound
October 22, 2018 - Scientists discover genes that contribute to ADHD development
October 22, 2018 - Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma
October 22, 2018 - FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis
October 22, 2018 - At-home biofeedback therapy effective in relieving difficult-to-treat constipation
October 22, 2018 - Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer
October 22, 2018 - People with periodontal disease less likely to reach healthy blood pressure ranges
October 22, 2018 - Phase III LONSURF study shows progression-free survival in patients with refractory metastatic gastric cancer
October 22, 2018 - Primary care doctors ‘not doing enough’ to curb STDs
October 22, 2018 - Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer
October 22, 2018 - ImmunoGen announces study results of platinum-resistant ovarian cancer therapy at ESMO 2018 Congress
October 22, 2018 - Study findings could set new standard of care for advanced anal cancer
October 22, 2018 - Erlotinib improves progression-free survival in EGFR mutated NSCLC
October 22, 2018 - Pain, insomnia, and depression often drive osteoarthritis patients to seek medical care
October 22, 2018 - The International Society of Refractive Surgery honors Vivior Chairman with Casebeer Award
October 22, 2018 - Multi-strain probiotic helps reduce chemotherapy-induced diarrhea in cancer patients
October 22, 2018 - Study shows potential of avelumab plus axitinib as new treatment option for patients with advanced RCC
October 22, 2018 - Vertex gets European CHMP positive opinion for KALYDECO to treat patients with cystic fibrosis
October 22, 2018 - Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients
October 22, 2018 - Prostate radiotherapy improves survival in men with low burden of metastatic disease
October 22, 2018 - Duration of respiratory disturbances may better predict mortality risk from OSA
October 22, 2018 - Free phone app helps low-income obese patients to lose weight
October 22, 2018 - Immunotherapy with nivolumab and ipilimumab may improve survival in patients with MSI-high metastatic colorectal cancers
October 22, 2018 - FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma
October 22, 2018 - Compression Collar May Protect Brain of Female Soccer Players
October 22, 2018 - Technique visualizes neuron communication
October 22, 2018 - Advancement in medical imaging methods for health care
October 22, 2018 - Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis
October 22, 2018 - Immunotherapy increases survival in some patients with metastatic triple negative breast cancer
October 22, 2018 - Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma
October 22, 2018 - LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer
October 22, 2018 - Brainlab unveils ExacTrac Dynamic at ASTRO meeting in San Antonio, Texas
October 22, 2018 - Not exercising is worse than smoking, diabetes or heart disease finds study
October 22, 2018 - Shorter course of trastuzumab could be an option for women with HER2+ early breast cancer
October 22, 2018 - Map of Mouse Hippocampus Could Be Weapon Against Alzheimer’s
October 22, 2018 - Psychotropic polypharmacy is common in Alzheimer’s disease
October 22, 2018 - Texas A&M and UTA establish Texas Genomics Core Alliance
October 22, 2018 - Analyzing mouse’s potential as animal model of decision-making
October 22, 2018 - Radiotherapy can prolong survival in prostate cancer
October 22, 2018 - A genetic mutation involved in relapse
October 21, 2018 - Report reveals growing impact of cannabis on young people
October 21, 2018 - NSF awards $5 million grant to help scientists magnify societal impact of research
October 21, 2018 - Fertility Rates Down for Each Urbanization Level 2007 to 2017
October 21, 2018 - Genetically engineered 3-D human muscle transplant in a murine model
October 21, 2018 - Moms’ tight work schedules may affect their children’s sleep
October 21, 2018 - AHA: No Direct Link Between Preeclampsia and Cognitive Impairment, Study Finds
October 21, 2018 - Weight loss success linked with active self-control regions of the brain
October 21, 2018 - Scripps researchers successfully test potential new smoking-cessation treatment in rodents
October 21, 2018 - More accurate and less stressful way to measure a baby’s heartbeat
October 21, 2018 - Researchers show better cardiorespiratory fitness leads to longer life
October 21, 2018 - Healthy candies for diabetic patients
October 21, 2018 - Environment impact of microplastics remains unclear
October 21, 2018 - Antibiotics for appendicitis? Surgery often not needed
October 21, 2018 - AHA and AMA recognize more than 800 medical practices, health systems for blood pressure control
October 21, 2018 - Scientists obtain clearest ever image of Ebola virus protein
October 21, 2018 - Study reveals connection between two proteins known to be hyperactive in cancer
October 21, 2018 - Gabapentin Beats Pregabalin for Chronic Sciatica
October 21, 2018 - Cosmetic surgeons offering incomplete information for breast augmentation customers
October 21, 2018 - Chronic sleep disruption in early adult life accelerates AD-related tau pathology
October 21, 2018 - Take 10 for Mindfulness – Drugs.com MedNews
October 21, 2018 - Length of breathing disruption in OSA may be better predictor of mortality risk
October 21, 2018 - ApoE4 gene linked with chronic inflammation increases risk for Alzheimer’s disease
October 21, 2018 - Mother-daughter conflict associated with suicide risk in abused adolescent girls
Could a Hot Cup of Tea Preserve Your Vision?: MedlinePlus Health News

Could a Hot Cup of Tea Preserve Your Vision?: MedlinePlus Health News

image_pdfDownload PDFimage_print

HealthDay news image

THURSDAY, Dec. 14, 2017 (HealthDay News) — A spot of hot tea in the afternoon might help you save your sight, new research suggests.

The study of U.S. adults found that people who drank hot tea on a daily basis were 74 percent less likely to have glaucoma, compared to those who were not tea fans.

Experts were quick to stress that it may not be tea, itself, that wards off the eye disease. There could be something else about tea lovers that lowers their risk, said senior researcher Dr. Anne Coleman.

But the findings do raise a question that should be studied further, according to Coleman, a professor of ophthalmology at the University of California, Los Angeles.

“Interestingly,” she said, “it was only hot, caffeinated tea that was associated with a lower glaucoma risk.”

Decaf tea and iced tea showed no relationship to the disease. Neither did coffee, caffeinated or not.

It’s hard to say why, according to Coleman. “Is there something about the lifestyle of people who drink hot tea?” she said. “Do they exercise more, for example? We don’t know.”

Glaucoma refers to a group of diseases where fluid builds up in the eye, creating pressure that damages the optic nerve. It’s a leading cause of blindness in older adults, according to the American Academy of Ophthalmology (AAO)

Some people face a higher risk than others, the AAO says: They include blacks, people with a family history of glaucoma, and people with high blood pressure, diabetes or other conditions that affect blood circulation.

Some studies have suggested that people who drink a lot of coffee have a heightened glaucoma risk. Others have hinted that caffeine can temporarily boost pressure within the eye.

On the other hand, some studies have failed to find a coffee-glaucoma link, Coleman said.

Her team decided to see whether there is any connection between glaucoma and not only coffee, but tea or soda — caffeinated or not. So the researchers turned to data from a nationally representative government study where U.S. adults underwent eye exams and filled out nutrition surveys.

Of nearly 1,700 survey participants, 5 percent had glaucoma.

Overall, Coleman’s team found, the odds of having glaucoma were 74 percent lower among people who said they drank hot tea more than six times a week, versus non-drinkers.

That was with a number of other factors taken into account — including age, weight, diabetes and smoking habits.

Still, it’s impossible to conclude that tea, itself, deserves the credit, Coleman said.

Other lifestyle factors might be at work, she explained. And with diet, Coleman noted, it’s always hard to disentangle any effects of a single food or nutrient from the rest of a person’s eating habits.

That said, she pointed to some theoretical reasons why tea could be beneficial. It contains a range of plant chemicals that may fight inflammation and protect body cells from accruing damage.

The findings were published online Dec. 14 in the British Journal of Ophthalmology.

For now, Coleman recommends focusing on some proven steps.

“The important first step is to not take your eyes for granted,” she said. “Go in for that comprehensive eye exam.”

Dr. Davinder Grover, a clinical spokesperson for the AAO, agreed.

He said people should get a “baseline” eye exam with an ophthalmologist at the age of 40 — a time when early signs of eye disease may start to emerge.

Some people may need to start earlier, Grover noted — such as those with relatives who developed glaucoma early, in their 40s or 50s.

As for prevention, there is no surefire way to ward off glaucoma. But people may curb the risk by minding their overall health — their cardiovascular health, in particular, he said.

“So if you have diabetes or high blood pressure, try to get that under control,” Grover said.

Coleman stressed another point: Even when glaucoma is already present, it can be treated — with eye-drop medications or laser surgery, for example. That can prevent damage to the optic nerve and vision loss.

Damage to the optic nerve is not, however, reversible, Grover said. So early detection and treatment are vital.

“The name of the game is prevention,” Grover said. “If we catch glaucoma early and treat it appropriately, the vast majority of the time, we win.”

SOURCES: Anne Coleman, M.D., Ph.D., professor, ophthalmology, University of California, Los Angeles; Davinder Grover, M.D., M.P.H., clinical spokesperson, American Academy of Ophthalmology, and ophthalmologist, Glaucoma Associates of Texas, Dallas; Dec. 14, 2017, British Journal of Ophthalmology, online

News stories are written and provided by HealthDay and do not reflect federal policy, the views of MedlinePlus, the National Library of Medicine, the National Institutes of Health, or the U.S. Department of Health and Human Services.

Tagged with:

About author

Related Articles